Endotoxicosis During Liver Injury and Regeneration by Harig, James M.
Loyola University Chicago 
Loyola eCommons 
Master's Theses Theses and Dissertations 
1986 
Endotoxicosis During Liver Injury and Regeneration 
James M. Harig 
Loyola University Chicago 
Follow this and additional works at: https://ecommons.luc.edu/luc_theses 
 Part of the Medicine and Health Sciences Commons 
Recommended Citation 
Harig, James M., "Endotoxicosis During Liver Injury and Regeneration" (1986). Master's Theses. 3419. 
https://ecommons.luc.edu/luc_theses/3419 
This Thesis is brought to you for free and open access by the Theses and Dissertations at Loyola eCommons. It 
has been accepted for inclusion in Master's Theses by an authorized administrator of Loyola eCommons. For more 
information, please contact ecommons@luc.edu. 
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. 
Copyright © 1986 James M. Harig 
ENDOTOXICOSIS DURING LIVER INJURY AND REGENERATION 
by 
Jam es M. L!:f~rig 
A Thesis Submitted to the Faculty of the Graduate School of Loyola University 
of Chicago in Partial Fulfillment of the Requirements 
for the Degree of Master of Science 
May 
1986 
ACKNOWLEDGEMENTS 
I would like to express my sincere appreciation to Dr. James P. Filkins 
for his invaluable guidance during my graduate education. My warmest gratitude 
is also extended to Loretta Dalaskey, Elaine McLaughlin, Randy Powell, Gail 
Kummer and Kathleen Goelz for their expertise and assistance in the preparation 
of this thesis. 
Lastly, I wish to acknowledge the members of my committee, Dr. 
Mohammed M. Sayeed, Dr. Stephen B. Jones and Dr. Robert P. Cornell. 
ii 
VITA 
James M. Harig was born 9 October 1955 in Chicago, Illinois, the son of 
John and Anne Harig. 
He received his elementary education from Immaculate Conception School 
and his secondary education from St. Patrick High School, both located in 
Chicago. 
In September of 1973, he entered the University of Notre Dame, Notre 
Dame, Indiana and was awarded the degree of Bachelor of Science in May of 1977. 
In June of 1977, he enrolled in the Loyola University of Chicago Stritch 
School of Medicine and was awarded the degree of Doctor of Medicine in June 
of 1980. This was followed by a residency in Internal Medicine at Loyola 
University Medical Center from June of 1980 until June of 1983. 
In June of 1982, he began his graduate studies in the Department of 
Physiology, Loyola University of Chicago. His studies were carried out under 
the guidance of Dr. James P. Filkins and were supported by a Basic Science 
Fellowship. 
Currently, Dr. Harig is a Fellow in Academic Gastroenterology with Dr. 
Konrad Soergel at the Medical College of Wisconsin. 
iii 
TABLE OF CONTENTS 
ACKNOWLEDGEMENTS ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
\fl'"f }\ ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
LIST OF TABLES •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
INTRODUCTION •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
LITERATURE REVIEW ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Endotoxin-organism interactions ••••••••••••••••••••••••••••••••••••••••••••••••••• 
The Ii ver ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••.•••••••••••••••••••••••• 
Hepatocytes-metabolic function ••••••••••••••••••••••••••••••••••••••••••••••••••• 
Kupffer cells-immunologic function •••••••••••••••••••••••••••••••••••••••••••••• 
Kupff er cell-parenchymal cell interactions ••••••••••••••••••••••••••••••••••• 
Hepatic regeneration model ••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
The study ••.•••••••••••••••••••••••••••••••••••••••••••••••••••••.•.••••••••••••••••••••••••• 
MA TE RIALS AND METHODS ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Animals •••••••••.••••••••••••••••••••••••••••••••••••••••••••••••••.•••••••••••••••••••••.•••• 
Partial hepatectomy and hepatic regeneration ••••••••••••••• ~ ••••••••••••• 
Assessment of liver regeneration ••••••••••••••••••••••••••••••••••••••••••••••••• 
In vivo endotoxin sensitivity •••••••••••••••••••••••••••••••••••••••••.•••••••••••••• 
Measurements •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Lethality ••••••••••••••••••••••••••••••••••••.•.••••••••••••••••••••••••••••••••••••••••• 
Plasma glucose and lactate •••••••••••••••••••••••••••••••••••••••••••••.•••••• 
Assessment of in vivo gluconeogenesis .•••••••••••••••••••••••••••••••••• 
Assessment of phagocytic function •••••••••••••••••••••••••••••••••••.••••• 
Data analysis ••••••••••••••••••••••••••••••.••••••••••.•••••••••••••••••••••••••••••••••••• 
RES UL TS •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Assessment of Ii ver regeneration •••••••••••••••••••••••••••••••••••••••••••••••• 
Lethality •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Terminal plasma glucose and lactate •••••••••••••••••••••••••••••••••••••••••• 
In vivo gl uconeogenesis ••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
Assessment of phagocytic function •••••••••••••••••••••••••••••••••••••••••••••• 
DISCUSSION •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
SUMMARY OF CONCLUSIONS •••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• 
BIBLIOGRAPHY •••••••••••••••••••••••••••••••••••••••••••••••••..••••••••••••••••••••••••••••••• 
iv 
Page 
ii 
iii 
v 
1 
3 
3 
5 
6 
9 
12 
14 
16 
18 
18 
18 
19 
19 
20 
20 
20 
21 
21 
23 
24 
24 
24 
26 
27 
31 
33 
40 
41 
LIST OF TABLES 
TABLE PAGE 
1. Assessment of Liver Regeneration 
Following 7096 Hepatectorny ..................................................... . 25 
2. Endotoxic Lethality Following 70% 
Par ti al H epatectom y •••••••••••••••••••••••••.•••••••••••••••••••••••••••••••••••••••• 28 
3. Terminal Plasma Glucose and Lactate 
Levels Following Endotoxi cosis ................................. ................ . 29 
4. Evaluation of In Vivo Gluconeogenesis 
Following Hepatectomy ............................................................ . 30 
5. Effect of Hepatectomy on 
Colloidal Carbon Clearance ....................................................... . 32 
v 
INTRODUCTION 
The syndrome of endotoxicosis is an extremely complex and poorly 
understood organismic response to gram negative bacterial cell wall components. 
Mammalian responses to endotoxin occur along a continuum ranging from the 
physiologic (the normal percolation of gut-derived endotoxins in the portal 
circulation) to the extreme pathophysiologic (septic shock and death). Virtually 
all organ systems are affected either directly or indirectly (via mediators) in 
endotoxicosis (31); thus it becomes an extremely difficult task to define the 
mechanisms responsible for the often dramatic derangements of the organism's 
homeostasis. Therefore, most investigators focus on individual phenomena 
observed during endotoxicosis and sepsis such as cardiovascular, hormonal, 
immunological, hematologic or metabolic effects. 
A key metabolic change involves the profound alterations in glucose 
metabolism in the endotoxic state. Early hyperglycemia followed by late severe 
hypoglycemia and hyperlactacidemia characterize the time course of endotoxic 
shock. The early hyperglycemia has been attributed to glycogenolysis and 
increased gluconeogenesis by the liver. Conversely, the failure to maintain 
adequate plasma glucose levels terminally is due to increased peripheral glucose 
oxidation, exhaustion of Ii ver glycogen stores, and depression of hepatic 
gluconeogenesis. 
As in normal metabolism, the liver plays a central and critical role in 
the perversions of glucose metabolism observed in endotoxicosis (57,58). The 
liver is comprised mainly of parenchymal cells (hepatocytes) and endothelial 
cells (mostly Kupffer cells). Parenchymal cells carry out the synthesis, storage 
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and release of glucose, while the Kupffer cells perform an immunodefensive 
function by clearing the portal circulation of bacteria, viruses, endotoxin and 
senescent erythrocytes (46). These two cell types and their respective functions 
appear to be closely interrelated in the metabolic pathophysiology of 
endotoxicosis. Indeed, endotoxin appears to be initially taken up by Kupffer 
cells as well as other macrophages of the mononuclear phagocyte system (MPS). 
Following this uptake, the MPS synthesizes and liberates various mediators which 
may initiate a multitude of effects in all organ systems. With their anatomical 
proximity to the blood in the hepatic sinusoids and to the hepatocytes, Kupffer 
cells and their mediators represent important effectors of altered glucose 
metabolism in endotoxicosis. 
One method to study the role of the liver in endotoxicosis is to perturb 
the delicate balance of the liver and its cellular components ii') the environment 
of the total organism. Resection of a large percentage of the liver and its 
subsequent regeneration provides just such a perturbation. By observing the 
effects of endotoxin during various stages of liver injury and regeneration, 
possible mechanisms of the liver's role in the development of the metabolic 
derangements of endotoxic shock can be defined. Also, because the different 
hepatic cellular components regenerate to differing degrees and time frames, 
we can investigate the mechanisms and interrelationships of the separate cell 
types, namely the hepatocytes and the Kupffer cells. 
LITERATURE REVIEW 
ENDOTOXIN - ORGANISM INTERACTIONS 
The interactions between an organism and bacterial endotoxins are poorly 
understood phenomena. There are many reasons for this confusion. Firstly, 
endotoxins comprise a variety of bacterial ceU wall components consisting mainly 
of lipopolysaccharides. These lipopolysaccharides are complex molecules which 
vary in their structure depending on such factors as the species, method of 
isolation, intraspecies mutations, etc. Thus, scientifically, it is a difficult task 
to study such a heterogenous compound (60). 
Secondly, responses to endotoxins by the mammalian organism include 
virtuaUy all organ systems at all levels of organization. These responses may 
range from subtle scientific observations such as alterations of plasma membrane 
fluidity (44,74) to the full blown picture of septic shock and multiple organ 
system failure. These responses may vary depending on species differences, 
fed and fasted state, season and a multitude of other variables. Therefore, a 
myriad of reactions by the organism forms a second source of difficulty. 
Another problem in studying endotoxin host interactions lies in the fact 
that not all effects of endotoxin are truly toxic (as the name implies) to the 
organism. Certainly, there are instances when endotoxin is relatively innocuous. 
An obvious case in point occurs in the normal gastrointestinal tract lumen where 
large numbers of bacteria and their cell wall components reside without apparent 
ill effects. Likewise, endotoxin can be detected using the Limulus lysate test 
in the portal circulation of perfectly healthy humans. Bacteremia following a 
3 
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dental procedure, a proctoscopy or even a hard bowel movement usually occurs 
without consequence. Besides being innocuous, there are instances where 
endotoxin is felt to be beneficial to the organism. Cornell has provided data 
demonstrating a possible beneficial role for gut derived endotoxin in liver 
regeneration (21). In addition, endotoxin percolating down the intestine may 
be necessary for normal colonic function as evidenced by the development of 
"exclusion colitis" which occurs when the fecal stream is surgically diverted 
from a segment of colon. The ability of endotoxins to act as immunomodulators 
is well known; they have been shown to increase general host resistance (37), 
stimulate interferon production (43) and possibly attenuate the graft vs. host 
reaction following bone marrow transplantation (48). Endotoxin effects run the 
gamut from the fulminant deadly scenario of shock to the symbiotic existence 
of bacteria in the intestinal lumen. 
Finally, most of the actions of endotoxin are not direct or primary in 
nature. That is, the observed phenomena (e.g. galactosamine-induced hepatitis) 
are mediated through a number of different intermediate steps of which little 
is known (5,14,75). For example, the fever produced by administration of 
endotoxin is felt to be caused by the elaboration of a thermoregulatory monokine 
termed endogenous pyrogen which is secreted by macrophages and acts on the 
hypothalamus (35). The hypothalamus then orchestrates the production of the 
fever initiated by phagocytosis of endotoxin by the macrophage. As in any 
cause and effect relationship, it becomes necessary to unravel these individual 
steps before one can understand the entire process. 
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THE LIVER 
The liver occupies a central role in endotoxin-organism interrelationships. 
Because it performs many functions in the normal physiologic state, it seems 
logical that the liver will contribute greatly to the pathophysiology of endotoxic 
shock. To demonstrate this point: 1) the liver synthesizes blood coagulation 
factors which are consumed in the syndrome of disseminated intravascular 
coagulation (DIC) observed in sepsis. 2) vasoactive substances such as serotonin 
are normally removed from the bloodstream by the liver. During endotoxemia, 
these substances escape and contribute to the altered hemodynamics. 3) 
Gluconeogenesis and glycogenolysis help to maintain a normal blood glucose. 
These metabolic processes fail during late sepsis causing profound hypoglycemia. 
Also, the failure of the liver to remove lactate produced during endotoxic shock 
aggravates the already existing acidosis and hypotension. 4) Bilirubin is cleared 
normally by the hepatocytes. Cholestasis and jaundice can result from 
endotoxemia (72,73). 5) Normal clearance of gut derived endotoxins and 
bacteria is depressed in sepsis. This defect is felt to enhance and perpetuate 
the syndrome of endotoxins. Also, the secretion of various immune mediators 
elaborated by Kupffer cells in the normal state is deranged in the septic state, 
leading to exaggerated host responses to these mediators. 
For the purposes of this study, only the metabolic and immunologic 
functions of the liver will be addressed. The liver has been traditionally divided 
into two parts: hepatocytes (parenchymal cells) and endothelial cells 
(predominantly Kupffer cells). The hepatocytes perform most of the metabolic 
and synthetic functions of the liver, while the Kupffer cells participate in the 
organism's immune responses as part of the mononuclear phagocyte system 
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(MPS). It will become clear from this review and study that these two cell 
types interact in an indivisible manner during the metabolic dyshomeostasis 
(19,30,32,34) of endotoxic shock. For the sake of clarity, these two hepatic 
components will be initially discussed as separate entities. 
HEPATOCYTES-METABOLIC FUNCTION 
As stated previously, the hepatocytes engage in a number of metabolic, 
synthetic and detoxifying functions. However, the most important metabolic 
responsibility is the maintenance of a normal blood glucose level. This is 
accomplished by the liver through glycogenolysis, gluconeogenesis and degradation 
of insulin which all tend to increase blood glucose. Conversly, the liver also 
engages in glycogenesis, clearance of glucose and receptor binding of insulin to 
decrease blood sugar. 
Gluconeogenesis and subsequent delivery of glucose to other tissues occurs 
only in the liver and kidney, due partially to the fact that glucose 6-phosphatase 
is found only in these organs. The kidney, however, only contributes significantly 
to glucose homeostasis in times of prolonged starvation. Thus, the liver is for 
practical purposes the only gluconeogenic organ. The liver utilizes mainly 
pyruvate, lactate, glycerol and alanine (derived from catabolism of other amino 
acids) as gluconeogenic precursors. Gluconeogenesis therefore, serves to 
synthesize and deliver glucose back to the body by clearing metabolic 
"byproducts" (especially lactate) from the bloodstream. This clearance and 
synthesis phenomenon becomes quite important in endotoxic shock where there 
is a failure of gluconeogenesis. 
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Another important hepatic modulator of blood glucose involves the 
synthesis and breakdown of glycogen. Glycogenesis and glycogenolysis also take 
place in skeletal and cardiac muscle, but these organs utilize this glycogen 
locally with little or no systemic contribution (27). This source for blood sugar 
obviously depends on the temporal sequence to the fed state - early on it is a 
significant source, but its importance wanes as the organism progresses further 
into a fasted state. Like gluconeogenesis, it is dependent on the blood glucose 
level, fed or fasted state and hormonal milieu. Release of this hepatic glucose 
is quite sensitive to the "counter insulin" hormones, especially the 
catecholamines. Glycogen sources can be rapidly depleted during times of 
extreme stress, such as is seen in septic shock. 
The liver can also regulate blood sugar by clearance of hormones. 
Probably, the best example of this phenemenon is the clearance or 
"detoxification" of insulin. The effect of insulin on the liver is to lower the 
blood sugar via an increase in glycogenesis and an inhibition of gluconeogenesis. 
However, the liver can also "degrade" insulin so that it cannot exert its 
hypoglycemic effects on peripheral tissues. This poorly understood degradation 
of insulin has a net effect of maintaining blood glucose. 
This normal physiological maintenance of blood glucose by the liver is 
complexly altered in the time course of endotoxic shock (54). As stated before, 
the early stages of sepsis and endotoxemia is characterized by hyperglycemia, 
especially in the fed state (33). This hyperglycemia is felt to be due to a 
number of factors: l) absorption of dietary carbohydrates (important in the 
fed state). 2) increased glycogenolysis due to effect of stress/counterinsulin 
hormones on the liver (27). 3) increased gluconeogenesis due to a generalized 
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catabolic state which sends large quantities of gluconeogenic substrates to the 
liver. 4) relative insulin resistance of peripheral tissues and liver. This insulin 
resistance has been inferred by the presence of exagerrated insulin levels for 
the existing glucose levels. More profound hyperglycemia in the fed state leads 
to more deranged insulin levels which probably contribute to the eventual 
increased lethality of endotoxin in fed animals. Following the hyperglycemia is 
a transition phase of euglycemia. 
More dramatic alterations of glucoregulation occur in the later 
hypoglycemic phase of endotoxicosis. This metabolic derangement precedes and 
then lasts through the terminal stages of coma, hypotension and death observed 
in septic shock. The causes of this hypoglycemia include: I) anorexia and 
cessation of feeding probably due to alterations of gastrointestinal motility (76) 
and effects of monokines on the hypothalamus 2) exhaustion 0f glycogen stores 
resulting from prolonged sympathetic drive, hepatic insulin resistance and 
decreased delivery of glucose from the intestine 3) increasing glucose oxidation 
occurring in the periphery because of inappropriate elevations of immunoreactive 
insulin as well as nonsuppressible insulin like activity (13,28). 4) depression of 
gluconeogenesis which is not related to decreased delivery of gluconeogenic 
substrate (15,25,41). Rather, it is a failure of the parenchymal cell gluconeogenic 
enzyme system. This failure is due to the effect of various immunometabolic 
regulators elaborated by the mononuclear phagocyte system. This concept of 
glucoregulatory monokines will be discussed in more detail later in this treatise. 
The terminal stages of endotoxic shock are characterized metabolically 
by the appearance of profound hypoglycemia and hyperlactacidemia. The 
hypoglycemia results from the continued influence of the aforementioned factors. 
9 
The hyperlactacidemia occurs because of increased peripheral lactate production 
(because of hypoperfusion and tissue hypoxia) and decreased lactate clearance 
by malfunctioning hepatocytes. This hyperlactacidemia aggravates existing 
acidosis, perpetuating a vicious cycle of acidosis, hypotension and circulatory 
collapse. At this point, the shock scenario is irreversible and death of the 
animal soon follows (68). 
KUPFFER CELLS-IMMUNOLOGIC FUNCTION 
The Kupffer cells are resident macrophages which line the hepatic 
sinusoids. These cells are of bone marrow origin, but they also are capable of 
cell division. Along with blood monocytes and other resident macrophages 
(spleen, lung, etc.) they collectively comprise the mononuclear phagocyte system. 
This system interacts with all organ systems and classically· its role has been 
ascribed to host defense. Indeed, its wide range of immunodefensive functions 
have been known for some time. In addition, numerous other functions such 
as tumor defense, metabolism and endocrinological control have been related 
to the MPS. For this discussion, focus will be placed on K upffer cell-endotoxin 
interactions. 
The MPS is responsible for the removal of bacterial endotoxin. An 
injected dose of intravenous endotoxin or colloidal carbon will be cleared by 
the MPS and be distributed roughly in the following manner: 70% liver, 20% 
spleen, 10% lung (8,10). Some endotoxin may be primarily taken up by 
hepatocytes (50). Gut derived endotoxin, however, is normally cleared entirely 
by the Kupffer cells. Evidence for this is the fact that in a healthy animal 
systemic blood rarely tests positive for endotoxin by the Limulus assay. However, 
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portal blood commonly gives a positive test. When there is liver disease or 
portasystemic shunting (as in alcoholic cirrhosis), then the systemic circulation 
will show evidence of endotoxin. 
This ongoing release of endotoxin into the portal circulation appears to 
be a quite healthy and physiological situation (39). Dead gram negative (and 
some gram positive) bacteria, residing primarily in the colon provide the source 
of this gut derived endotoxin. It appears that this continuing challenge to the 
Kupffer cells may act as a "groomer" to the MPS and the liver. Reductions in 
the endotoxin "load'' in the portal circulation will alter RES function. Animals 
on antibiotics (4) as well as germfree rats (3) will demonstrate decreased 
phagocytic activity. In addition, maintenance of liver size, alteration of certain 
hepatic enzyme activities, regulation of hepatic regeneration and secretion of 
pancreatic hormones all appear to be somewhat dependent -on this continual 
delivery of lipopolysaccharides from the intestine to the liver (20). There may 
indeed be numerous other physiological functions for endotoxin in the portal 
circulation. Thus, the symbiotic relationship between an animal and its gut 
flora is much more complex than merely the provision to the animal of vitamin 
K precursors by the bacteria. 
What then causes Kupffer cells to react so violently to endotoxin in the 
syndrome of endotoxic shock? This question is difficult to answer in light of 
the previous discussion, since these cells are continually phagocytosing endotoxin 
without any ill effects to the animal. Certainly, it is a dose related phenomenon 
and the presence of endotoxin in the systemic circulation also is an important 
factor (61,67). Regardless of amount and location in the bloodstream, the 
endotoxin is cleared initially by the MPS, mostly by the hepatic macrophages. 
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This ingestion of lipopolysaccharide by the Kupffer cells causes the release of 
mediators which initiate the various sequelae of endotoxicosis (35). These 
mediators may consist of substances which are not normally liberated, or they 
may merely be "physiological" substances released in exagerrated amounts. 
Interleukin-! {IL-1) is one such mediator (56). IL-1 is present in the normal 
and endotoxic animal. This protein substance has been demonstrated to induce 
lymphocyte proliferation in vitro and is also similar to the endogenous pyrogen. 
Many more possible functions of IL-I are currently under study. Most probably 
IL-I will indeed be shown to mediate a wide variety of immunologic and 
metabolic functions in a way which is analogous to the many actions of insulin. 
Whether or not IL-I is the only monokine responsible for endotoxic shock remains 
to be shown pending further study (45). 
One final aspect of endotoxin-Kupffer cell interactions which should be 
addressed is the phenomenon of tolerance. Whereas lipopolysaccharide is usually 
lethal in relatively small quantities, an animal can be made virtually invincible 
to its effects by repeated incremental subcutaneous injections (65,70). A single 
endotoxin injection can protect against mixed flora septic mortality (71). There 
is also a C3H/HeJ strain of mice which is extremely resistant to endotoxin 
while the syngeneic strain (C3HeB/FeJ) is exquisitely sensitive (52,53). This 
phenomenon of tolerance may be in part humorally mediated (55), as 
demonstrated in Braude and Ziegler's work with the J5 mutant E. coli antiserum 
and its attenuation of septic shock in humans (79) and animals (l I). An actual 
macrophage tolerance probably is also an important factor. This "indifference" 
of the macrophage to endotoxin is poorly understood as it relates to other 
macrophage functions such as phagocytosis. Repeated doses of endotoxin will 
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eventually produce a hyperphagocytic MPS. However, the resistant C3H/HeJ 
strain actually demonstrates a defect in phagocytosis. 
Manipulations which alter various functions of the MPS have inconsistent 
results on endotoxic sensitivity. Administration of lead salts will increase 
lethality of endotoxin by a factor of 10,000 (24,29), yet it has also been shown 
to stimulate hepatic proliferation (16). In contrast, glucan also stimulates 
proliferation yet was shown to protect against Staphylococcus aureus septicemia 
in normal and leukemic mice (22). In contrast, glucan sensitized mice to 
endotoxin in other studies (35,36). Colloidal carbon "blockades" the MPS in 
regard to further phagocyte activity, but also sensitlzes the animal to shock. 
Perhaps this blockade is in reality an activation of the MPS system in regard 
to mediator release. There are numerous other examples oi MPS perturbations 
which also give inconsistent results in regard to alterations in endotoxin response. 
Thus, there exist some critical unexplained factors in the endotoxin-phagocytes-
Kupff er cell response which will ultimately determine the organism's response 
along the continuum which ranges from resistance to death (23). 
KUPFFER CELL - PARENCHYMAL CELL INTERACTIONS 
Despite the preceding discussion, it is more correct to envision the 
Kupffer cells and hepatocytes as a single functional unit. Since all of the 
hepatic arterial and portal venous blood must percolate through the hepatic 
sinusoids, the Kupff er cells will oversee and process any circulatory contents 
before these substances reach the hepatocytes (49,59,78). Therefore, the 
perisinusoidal space (between the sinusoidal endothelial lining and the 
hepatocytes) will contain: 1) substances which the Kupifer cells allow to pass 
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unchanged. 2) substances which have been modified by the Kupffer cells. 3) 
substances (mediators or monokines) synthesized and released by the Kupffer 
cells in response to circulatory signals. The understanding of this "social 
behavior" (as Popper states it) of liver cells is still in its infancy (63). It is 
without question, however, that these cell to cell communications exist and 
certainly play a significant role in the metabolic dyshomeostasis of septic shock. 
As stated earlier, the hypoglycemia observed in sepsis is a well known 
phenomenon. One of the reasons for this failure to maintain adequate blood 
glucose is a decrease in hepatic gluconeogenesis. Strong evidence exists that 
this hepatocyte failure is effected through Kupffer cell monokines. Filkins and 
Cornell showed that hepatocytes from an endotoxic animal demonstrated 
depressed gluconeogenesis, but that hepatocytes from a non-toxic fasted animal 
synthesized glucose normally, even when endotoxin was added to the cells 
directly. Mc Callum (52) investigated PEPCK enyzme activity in endotoxic 
mice and found it to be less than half of those values found in control mice. 
Again, endotoxin added directly to hepatocytes in vitro did not depress PEPCK 
activity. In another study, McCallum (52) measured PEPCK activity using 
combinations of hepatocytes and Kupffer cells from C3 HeB/FeJ (sensitive) and 
C3H/HeJ (resistant) mice. He found that the critical factor for depression of 
PEPCK activity was the presence of the endotoxic "sensitive" Kupffer cells. 
These studies all seem to lend credence to the fact that the Kupff er cells are 
causing a hepatocytic gluconeogenic failure. 
Certain activities and factors have been studied relating to this depression 
of gluconeogenesis. Berry (80) and his group have extensively studied a 
macrophage mediator termed glucocorticoid antagonizing factor (GAF). This 
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product of endotoxic macrophages inhibits the induction of gluconeogenic 
enzymes by corticosteroids. Insulin has been shown to contribute significantly 
to endotoxic shock (12). Filkins described a macrophage insulin-like activity 
(MILA} derived from peritoneal exudate macrophages which increases peripheral 
tissue glucose oxidation. Filkins and Yelich investigated another macrophage 
product which stimulates pancreatic insulin secretion. This monokine was termed 
macrophage insulin-releasing activity (MIRA) and appears to play a role in the 
hyperinsulinism of sepsis. Leukocyte endogenous mediator (LEM), now known 
as interleukin-! has been shown to mobilize hepatic glycogen and elevate plasma 
insulin and glucagon levels. As these factors and activities are purified and 
studied further, they may all be of similar structure. Perhaps just one monokine 
such as interleukin-! will demonstrate all of these actions on glucose regulation. 
HEPATIC REGENERATION MODEL 
This thesis studied liver and endotoxin interactions using the rat partial 
hepatectomy and regeneration model. The following description of the pertinent 
hepatic events occurring temporally during this experimental model will aid in 
understanding both the rationale and advantages of this system for our study. 
This partial hepatectomy model was first described in 1921 by Higgins 
and Anderson (42). It involves resection of the left lateral and median lobes 
of the rat liver resulting in a 7096 reduction of liver mass. No special 
postoperative care is needed and the operation results in roughly a 9596 survival 
rate (See Methods section for further details of the operative procedure). Since 
1921, a large volume of literature has accumulated on the process of liver 
injury and regeneration utilizing this model. The model has also been used 
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extensively to study areas such as cell division, malignancy growth factors, DNA 
and RNA synthesis and endocrine control (17 ,51). 
The rat liver possesses both an enormous functional reserve and a large 
capacity for regeneration. Vic (77), using testosterone and Gaub (40) have been 
able to induce full regeneration with a 50% survival after 90% hepatectomy. 
Various biochemical indices of liver functions such as serum bilirubin, prothrombin 
time and serum albumin are only minimally perturbed immediately following 
70% resection (2,69). Plasma glucose undergoes only a slight decline foUowing 
70% partial hepatectomy. Inducement of gluconeogenesis and early glycogen 
depletion maintain this plasma glucose level, indeed, little if any hypoglycemia 
occurs in fasted rats following as much as a 70% hepatectomy (17). This 
prevention of early hypoglycemia seems to be a critical hepatocytic function 
as the vast functional reserve or "metabolic machinery" of the· hepatocyte shifts 
to ensure the maintenance of plasma glucose (62). Hypoglycemia occurring in 
the early post hepatectomy period results in delayed liver regeneration (18). 
Once this maintenance of blood glucose is assured, the liver begins its 
process of regeneration. The hepatocytes are the first to regenerate, followed 
by the sinusoidal cells and the ductal cells. Incorporation of radiolabelled 
thymidine into hepatocyte DNA begins after twelve hours with peak labelling 
occurring at twenty to twenty four hours post hepatectomy (66). Histological 
evidence of mitosis follows DNA labelling in 6-8 hours. During the first twenty 
four hours, a massive infiltration of fat vacuoles located in the hepatocytes 
occurs, disappearing by forty eight hours. The liver doubles in size after two 
days and usually approaches original weight by seven days. The entire hepatocyte 
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mass regenerates locally; existing hepatocytes undergo mitosis to entirely replace 
the resected parenchymal cell mass. 
Regeneration of Kupffer cells occurs in a somewhat different manner 
than regeneration of hepatocytes. The new Kupffer cells can come from two 
sources, either local proliferation or recruitment of bone marrow monocytes 
which transform into resident macrophages (Kupffer cells). Probably both sources 
contribute to the repopulation of the Ii ver, but controversy exists as to the 
relative importance of each source (9,38,64). A bone marrow source for Kupffer 
cells has been established in humans showing that the karyotype of Kupffer 
cells following liver or bone marrow transplant resembles that of the marrow 
whether it be transplanted or native (38,64). Bouwens has shown, however, that 
local proliferation is responsible for most of the early replenishment following 
partial hepatectomy (9). Kupff er cells lag behind parenchymal cells in their 
regeneration with peak thymidine labeling occurring at roughly forty two hours 
for sinusoidal cells versus the aforementioned twenty hours for hepatocytes. 
Also, the Kupffer cell population will double its original complement following 
resection, whereas the hepatocytes will only approach the prehepatectomy cell 
mass. Coincident with this exaggerated replenishment of K upffer cells is an 
increase in phagocytic activity (6,7,47). A hyperphagocytic state exists as early 
as three days post hepatectomy and can persist for as long as six months. 
THE STUDY 
From the above discussion it is clear that the process of liver injury and 
repair involves a dynamic orchestration of intracellular processes and cellular 
balances. Studying the organismic response to endotoxin during various times 
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in the injury and subsequent regenerative process may provide information 
regarding the roles of the hepatic cellular components and their interactions in 
the development of endotoxic shock. The liver injury/regeneration model can 
be used to alter the delicate homeostatic balance between hepatocyte and 
Kupffer cell. By studying alterations in the development of endotoxic shock 
and glucoregulation failure during regeneration, a clearer assessment may be 
made of the functions in septic shock of the hepatocyte, K upffer cell and most 
important, the hepatocyte-Kupffer cell unit. 
Specifically, this study addresses the following questions: 
1) Is susceptibility to endotoxic shock altered during acute liver injury and 
subsequent regeneration? 
2) Is the glucose and lactate dyshomeostasis observed in endotoxic shock also 
observed in this experimental model? Is it accelerated or attenuated? 
3) If alterations of endotoxic shock sensitivity are found, are these changes 
due to alterations of hepatocyte function, Kupffer cell function, or both? 
MATERIALS AND METHODS 
ANIMALS 
Healthy male rats of the Holtzman strain (Holtzman Company, Madison, 
Wisconsin) weighing 275-400 grams were used for all experiments. The rats 
were acclimated for a minimum of five days in the animal care facility of 
Loyola University Medical Center. They were maintained on a 12 hour light-
dark cycle (7:00 a.m. - 7:00 p.m., CST) and kept at an ambient temperature 
of 22oc (7 l.60F). The rats were fed Purina Rat Chow (Ralston Purina, St. 
Louis, Missouri) and water was provided ad libitum. Animals were fasted at 
4:00 p.m. on the day prior to the in vivo gluconeogenesis studies. For all other 
studies, rats were allowed free access to food. 
PARTIAL HEPATECTOMY AND HEPATIC REGENERATION 
Partial hepatectomy to induce liver regeneration was performed in a 
manner similar to the procedure described by Higgins and Anderson (42). All 
surgery occurred between 8:00 a.m. and 12 noon. Fed rats were placed under 
ether anesthesia, and a midline laparotomy was carried out from the xiphoid 
process caudad for a length of 2-3 centimeters. The left lateral and median 
lobes of the liver were delivered through the laparotomy by applying simultaneous 
pressure on the abdomen and thorax. Two ligatures of 2-0 silk were tightly 
placed around the vascular pedicles of these lobes. The lobes were then removed 
with a scissors as close to the ligature as possible. The abdominal musculature 
was closed with 3-0 silk, and the skin was closed using 3 or 4 wound clips. 
There was no special postoperative care. The rats were returned to the animal 
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care facility and given food and water ad libitum until the time of the subsequent 
experiments. Left lateral and medial lobectomy resulted in approximately a 
7096 removal of Ii ver mass. 
Sham partial hepatectomies were also carried out on rats age matched 
to the hepatectomized rats. These rats also underwent a midline laparotomy. 
The same lobes were delivered outside of the abdominal cavity, manipulated 
and replaced along with a 1 cm length of 2-0 silk ligature to control for any 
foreign body reaction. The abdomen was closed in an identical fashion. The 
sham rats received the same post op care. A third group of age matched 
controls received no operation. Subsequent experiments were performed on all 
three groups on the same postoperative days. 
ASSESSMENT OF LIVER REGENERATION 
The ratio of liver mass to total body mass was used as an assessment 
of hepatic regeneration following partial hepatectomy. Rats were weighed on 
the day of all experiments. After the studies were completed, the animals 
were autopsied and the livers were removed and blotted dry. The blotted livers 
were weighed, and these weights were then recorded as a percentage of total 
body mass. 
IN VIVO ENDOTOXIN SENSITIVITY 
The effect of liver injury (7096 hepatectomy) and subsequent hepatic 
regeneration on endotoxic sensitivity was studied by utilizing intravenous bolus 
injections of endotoxin as a model for endotoxicosis. 
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The three groups of animals (partial hepatectomy, sham hepatectomy and 
control) were allowed food and water until 8:00 a.m. on the morning of the 
experiments. Between 8:00 a.m. and 10:00 a.m., the rats were lightly 
anesthetized, weighed and injected with 10 mg/kg of Salmonella enteritidis 
lipopolysaccharide (Difeo Co., Lot No. 719776 and 706110). The rats were then 
allowed free access to water and observed for a twelve hour study period. 
These in vivo studies were performed on operated and control rats on days 1, 4, 
9, and 16 following partial hepatectomy. 
LETHALITY 
During the twelve hour study period, rats were sacrificed by decapitation 
when their righting reflex was judged to be lost (the rat would not attempt to 
regain normal posture after being placed in the supine positi.on). The loss of 
this reflex was taken to be indicative of a preterminal state of septic shock. 
These rats were tallied as deaths and the time to death (TTD) was recorded 
in minutes from time of injection to decapitation. Any rats surviving for twelve 
hours were tallied as "survivors" and assigned a TTD of 720 minutes. The 
survivors were then sacrificed and blood was collected for plasma glucose and 
lactate analyses. 
PLASMA GLUCOSE AND LACTATE 
All rats had blood specimens collected in 250 ul heparinized 
microcentrifuge tubes (Beckman Company, Lincolnwood, Illinois) at the time of 
decapitation. All specimens were promptly placed on ice. These samples were 
then centrifuged and assayed for plasma glucose and plasma lactate levels. 
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Plasma glucose measurements in mg/dl were obtained directly from a glucose 
analyzer (Yellow Springs Instruments, Model 23A, Yellow Springs, Ohio). 
Likewise, plasma lactate levels expressed in mmol/liter were obtained directly 
from a lactate analyzer (YSI Model 23L, Yellow Springs, Ohio}. All samples 
were analyzed twice if plasma quantity was sufficient, and the recorded value 
was the mean of the two measurements. 
ASSESSMENT OF THE IN VIVO GLUCONEOGENESIS 
An assessment of the gluconeogenic capability of the newly regenerated 
liver was performed using a modification of the intravenous alanine load test 
(26). Rats which were 4 days post hepatectomy and control rats were fasted 
for 18 hours prior to the experiment. Between 8:00 a.m. and 10:00 a.m. rats 
lightly anesthetized with intraperitoneal pentobarbital were injected with 100 
mg of mannoheptulose through the penile dorsal vein to block insulin release. 
Fifteen minutes later, baseline blood samples for glucose were collected from 
tail snips and the rats were immediately injected with 100 mg of alanine 
intravenously to provide substrate for gluconeogenesis. Blood samples were then 
collected at 15, 30, 45 and 60 minutes following alanine injection and analyzed 
for glucose content. 
ASSESSMENT OF PHAGOCYTIC FUNCTION 
It has been previously demonstrated that Kupffer cell phagocytic function 
is increased in the regenerating rat liver (6,7,47). In order to reconfirm this 
finding in this study, a check of phagocytic activity was performed by assaying 
the blood clearance of colloidal carbon. Rats 4 days post hepatectomy and 
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control rats were lightly anesthetized with intraperitoneal pentobarbital. 
Following anesthesia, the rats were injected with 1 cc of heparinzed saline into 
the dorsal penile vein to facilitate subsequent blood sampling via tail snips. 
The tail snips were then performed on both groups of rats. Baseline blood 
samples were collected from the tail snips into heparinized porcelain spot plates. 
Immediately following the baseline blood collection, the rats were injected with 
a solution of colloidal carbon (Gunther Wagner Pelikan Ink, 96 mg carbon/cc, 
West Germany). This stock ink was diluted with normal saline to a concentration 
of 48 mg/cc. Each rat received 16 mg colloidal carbon/100 g body weight for 
a total injected volume of roughly 1 cc. Taking the injection time as time 
zero, blood samples were then collected every three minutes for twenty one 
minutes from the tail snips and placed in heparinzed spot plates. Twenty five 
u1 of each of these blood samples was then mixed in a glass 13 X 100 mm 
cuvette with 5 cc of a 0.1 % Na2C03 solution. The cuvettes ·were then shaken 
vigorously to ensure a homogenous mixture. 
The samples were then measured on a Klett Colorimeter for clearance 
of colloidal carbon. Since measurement involved whole blood, a red filter was 
used in the colorimeter to correct for the presence of hemoglobin. After 
zeroing the instrument for each rat with its individual baseline "blood blanks," 
the light absorbance of subsequent samples for each rat was measured in "Klett 
units" (arbitrary units, which connote absorbance). For each rat sample, the 
Klett units were plotted against time on semilog paper and the best fit line 
was drawn through the points. Since this clearance is known to follow first 
order kinetics, the half time for clearance of the colloidal carbon was then 
determined from this line as an assessment of phagocytic function of the rat. 
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DAT A ANALYSIS 
Differences in lethality between the hepatectomy, sham hepatectomy and 
control groups was analyzed via a chi square analysis. Differences in plasma 
glucose, plasma lactate, liver wet weights, in vivo gluconeogenesis and the time 
to death in minutes were analyzed using a twcrtailed t-test. Analysis of increase 
in plasma glucose during the intravenous alanine load test was performed with 
a one tailed t-test since the glucose parameter will only behave in one manner 
or increase. 
RESULTS 
ASSESSMENT OF LIVER REGENERATION 
After the technique of partial hepatectomy was established in our 
laboratory, recovery from the operation (until the day of experimentation) 
approximated 95%. Recovery of the laparotomy rats approached 100%. The 
assessment of Ii ver regeneration in all experimental rats was measured against 
the intact liver weights of control and sham rats. Removed livers were blotted 
dry and weighed, and each individual liver was expressed as a percentage of 
the body weight of the respective rat. As Table 1 shows, liver regeneration 
by this parameter is nearly complete by 96 hours following resection. The 
regeneration percentage tends to drop off at 9 and 16 days after operation. 
This tendency is due to continued weight gain by the rats. Also, there is little 
difference between the liver percentages of control and sham laparotomy rats, 
indicating that both groups, as expected, are interchangeable in this study. 
LETHALITY 
Rats were sacrificed by decapitation when there was loss of the righting 
reflex (see Methods). Rats surviving twelve hours were then decapitated and 
termed survivors. All nonsurviving rats regardless of group appeared to undergo 
similar deaths; the rats displayed hyperventilation, piloerection, lethargy, 
irritability and diarrhea. Terminally, some rats displayed hypoglycemic 
convulsions. 
hemorrhage. 
At autopsy, the rats showed varying degrees of intestinal 
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TABLE I 
ASSESSMENT OF LIVER REGENERATION 
FOLLOWING 7096 HEPATECTOMY 
GROUPS N LIVER WEIGHTb 
CONTROL 23 3.45 + .09 
SHAM 39 3.16 + .06 
HEPATECTOMYa 
1 14 1.64 .±. .o8c 
4 20 3.22 + .13 
-
9 21 2.78 + .10 
-
16 18 2.65 + .09 
-
a Numbers refer to days following hepatectomy 
b Liver weight expressed as grams liver (wet weight)/grams total rat weight in 
percent :!. S.E.M. for each individual rat. 
c p less than .05 versus control on sham group. 
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Previous studies in our laboratory had demonstrated that the LD50 of ~ 
enteritidis injected intravenously for fed rats was roughly 10 mg/kg. Table 2 
shows that this held true for this investigation. The twelve hour survival for 
control and sham rats was 4396 and 4496 respectively. This also indicates that 
laparotomy alone did not increase endotoxic lethality and thus the sham 
hepatectomy rat behaves as a suitable control. There is a significant sensitization 
to endotoxic shock at four days post hepatectomy, which is abolished by nine 
days. The four day rats are more sensitive (with their regenerated livers) than 
the one day rats ( without significant regeneration) when the TTD is used as 
a measurement of sensitivity. Note also that the sixteen day rats are somewhat 
protected, although this difference did not reach statistical significance. 
TERMINAL PLASMA GLUCOSE AND LACTATE DURING ENDOTOXICOSIS 
In order to assess the failure of glucoregulation terminally, blood samples 
were collected at the time of sacrifice. These samples were analyzed for 
plasma glucose .and lactate levels. The table values for each group include 
blood levels for both survivors and nonsurvivors. There exists an obvious trend 
between increasing lethality and failure of glucoregulation, manifested by 
hypoglycemia and failure of the liver to clear lactate. However, nearly all of 
the lethalities, regardless of grouping, exhibited profound hypoglycemia and 
hyperlactacidemia. Taken together with the lethality figures, these data indicate 
an enhanced and earlier glucoregulatory failure in the four day hepatectomy 
group. It should be noted that previous studies established that all groups have 
normal plasma glucose and lactate levels prior to the injection of endotoxin. 
Thus, glucoregulation appears to be normal in all groups in the baseline state. 
Most striking about the data from Tables 2 and 3 is the fact that there is 
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earlier lethality and failure of glucoregulation in the four day group even when 
compared to the one day hepatectomy group. Thus, although the liver mass 
has been restored to nearly normal, its ability to maintain blood glucose during 
endotoxicosis is inferior to a liver which has roughly one half of normal weight. 
IN VIVO GLUCONEOGENESIS 
Because of the accentuated glucose dyshomeostasis observed in the four 
day hepatectomized rat, this study was carried out to assess any alteration in 
the gluconeogenic capacity of the regenerated liver. This was tested by using 
an alanine tolerance test. The animal's ability to undergo gluconeogenesis was 
optimized by performing the study in the fasted state, by injecting an excess 
of substrate (alanine) and by administering mannoheptulose to block any insulin 
response to increasing blood sugar. The data of Table 4 demonstrate that there 
is indeed a significant defect in the gluconeogenic capability of the newly 
regenerated liver. Note that fasting blood sugar levels are not different between 
the two groups. However, the maximal gluconeogenic capacity of the four day 
hepatectomy rat is suboptimal; this maximal gluconeogenic drive would be of 
critical importance during the development of hypoglycemia in the glycogen 
depleted, anorectic septic animal. Since it was done in vivo, this experiment 
does not differentiate this failure of gluconeogenesis between a primary 
hepatocytic defect or a secondary effects such as the influence of mono kines 
or other mediators. The test also makes certain assumptions which will be 
addressed in the Discussion section. 
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TABLE 2 
ENDOTOXIC LETHALITY FOLLOWING 
7096 PARTIAL HEPATECTOMY 
PERCENT TIME TO DEATHb 
GROUPS N SURVIVAL 
AT 12 HOURS (MINUTES) 
CONTROL 23 43 500 + 46 
SHAM 39 44 522 + 34 
HEPATECTOMYa 
1 14 14 341 + 57 
4 20 5c 199 + 32c 
9 21 43 525 + 49 
16 18 67 576 + 55 
a Numbers refer to days following hepatectomy. 
b Time to death expressed in minutes ± S.E.M. after injection of endotoxin. 
Rats surviving for twelve hours were assigned a value of 720 minutes. 
c p less than .05 versus control or sham group. 
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TABLE 3 
TERMINAL PLASMA GLUCOSE AND LACTATE LEVELS 
FOLLOWING ENDOTOXICOSIS 
GROUPS N PLASMA GLUCOSE mg/dlb PLASMA LACTATE mmol/Lb 
CONTROL 
SHAM 
23 
39 
HEPATECTOMYa 
1 13 
4 20 
9 21 
16 18 
56 + 9 
35 + 10 
10 + 3 
10 + 4 
48 + 9 
65 + 8 
Deaths and survivors are taken together for each group. 
a Numbers refer to days following hepatectomy 
b Values are :!: S.E.M. 
5.2 + .7 
5.8 + .7 
6.8 + .9 
7.7 + 1.0 
6.3 + .6 
3.4 + .7 
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TABLE 4 
EVALUATION OF IN VIVO GLUCONEOGENESIS 
FOLLOWING HEPATECTOMY 
GROUP N GLUCOSE VALUES (mg/dl)b 
TIMEa 
0 30 
CONTROL 12 112 + 6 164 + 6 
(PERCENT CHANGE) 46 
4 Days 23 110 + 4 148 + 5c 
Post Hepatectomy 
(PERCENT CHANGE) 35 
a Time in minutes following injection of I. V. Alanine. 
b Numbers are ± S.E.M. 
c p less than .01 when compared to control. 
d p less than .001 when compared to control. 
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178 + 5 
58 
157 
.'.!: 'd 
43 
60 
174 +7 
55 
161 + 5c 
-
46 
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ASSESSMENT OF PHAGOCYTIC FUNCTION 
Previous studies have shown the regenerating rat liver to have an increased 
number of Kupffer cells beginning roughly two days after hepatectomy. This 
increase in Kupffer cell number is parallelled by an increase in phagocytic 
capacity. Therefore, this phase of the study was implemented to assess the 
phagocytic activity of the four day hepatectomy rat in an attempt to relate 
this aspect of Kupffer cell function to the increased sensitivity to endotoxin. 
The rats with regenerated livers cleared the injection of colloidal carbon much 
faster than the control group (Table 5). The T~ was 6.8 minutes for the 
hepatectomy group vs. 14.0 minutes for the control group. This large increase 
in phagocytic capacity is in agreement with other studies which demonstrated 
increased clearance for colloidal gold, and labelled endotoxin. At autopsy, the 
distribution of carbon in the viscera was similar between experimental and 
control groups. The livers and spleens grossly were quite blackened with minimal 
blackening of the lungs. One interesting autopsy finding revealed that the 
spleens of the previously hepatectomized animals were often enlarged; in some 
cases the spleens had doubled in size. Other autopsies revealed that this 
enlargement was not present in laparotomy only rats. 
GROUP 
CONTROL 
4 DAY POST 
HEPATECTOMY 
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TABLE .5 
EFFECT OF HEPATECTOMY ON 
COLLOIDAL CARBON CLEARANCE 
N 
6 14.0 + 1.3 
5 6.8 ± .3b 
a T~ expressed in minutes +.S.E.M. for clearance of one half .of original whole 
blood colloidal carbon concentration. 
b p less than .001 when compared to control group. 
DISCUSSION 
The rat partial hepatectomy operation provides a quick and reproducible 
model for studying liver injury and regeneration. Once the technical aspects 
were mastered in our laboratory, nearly all of the rats survived for later study. 
The reproducibility of hepatic regeneration at various stages was fairly uniform 
as evidenced by the small standard errors in Table I. Thus, this model proved 
quite suitable to help answer some of the scientific questions which prompted 
this study. 
Table I demonstrates that rat liver regeneration is, as expected, quite 
rapid and is nearly complete by ninety six hours after surgery. The apparent 
increase in hepatic mass (assuming a 70% hepatectomy would leave 3.45x.3=1.04% 
liver) after only twenty four hours is probably due to the well described 
phenomenon of fatty infiltration for the first day following surgery. Although 
peak mitotic activity occurs at twenty hours, the major increase in the true 
hepatocytic mass occurs in postoperative days two to four. The slight decrease 
of liver weight percentage observed at days nine and sixteen probably reflects 
increased total rat mass as all rats continued to gain weight throughout the 
postoperative period. The remnants were nearly completely regenerated by day 
four and subsequently remained at a fairly constant weight. Although no 
histology was performed in our study, it has been previously shown that other 
than the early fatty deposition, the regenerating rat liver has nearly normal 
histology by light microscopy (except for an increased mitotic index). 
For the lethality studies, we attempted to utilize an endotoxin dose which 
approximated an LD50 for these rats. The rationale for this dosage lies in the 
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fact that we were unsure as to whether liver regeneration would sensitize or 
protect the rat in endotoxic shock. Table 2 shows that the survivals for the 
control and sham groups were as close to 5096 as one might expect considering 
the somewhat erratic organismic response to intravenous endotoxin. 
The most striking finding in the lethality study is the profound sensitivity 
of the 4-day rat to endotoxic shock, even with its nearly normal complement 
of the liver. In contrast, the I-day rat demonstrates better survival data despite 
the fact that its liver mass is markedly reduced and it also has undergone the 
stress of recent surgery. Therefore, this "newly regenerated" liver may react 
differently to endotoxin or merely decompensate quicker than either a 
nonregenerated liver or a recently resected liver. Other than the overabundance 
of Kupffer cells, the regenerated rat liver is felt to be the functional equivalent 
of an intact liver; the usual biochemical parameters are not a_\tered in the non-
stressed state. This study demonstrates that there are indeed profound 
differences in the response of the newly regenerated liver when stressed with 
endotoxin. 
In contrast to the 1 and 4 day rats, the 9 day rats show no difference 
in lethality or time to death, and the 16 day rats seem to enjoy somewhat of 
a protective effect. Thus, whatever alteration in the 4-day rat enhances the 
sensitivity to endotoxin disappears by day 9 following hepatectomy. What causes 
the relative protection observed in the sixteen day rat also is unclear; possible 
explanations for these data will be addressed later in this discussion. 
The well known relationship of hypoglycemia and hyperlactacidemia 
observed in terminal sepsis and endotoxic shock was again shown in this study. 
35 
Virtually all nonsurvivors, regardless of group, exhibited a profound failure of 
glucoregulation {and gluconeogenesis) as characterized by the low plasma glucose 
and high lactate levels {Table 3). As expected, these abnormalities correlated 
closely with the lethality and survival times of the animals. These data indicate 
that all groups succumb to similar metabolic deaths. The stage of liver injury 
and regeneration appears to alter mainly the temporal susceptibility to 
gluconeogenic failure and subsequent shock. 
What is the reason for this early metabolic failure? Certainly it would 
seem logical to implicate a hepatocyte malfunction, since the maintenance of 
euglycemia is a direct function of hepatocyte gluconeogenesis. The observed 
failure of hepatocyte glucoregulation may be either primary, secondary or most 
likely a combination of defects. 
Direct endotoxin effect on hepatocyte gluconeogenesis may indeed occur, 
but no convincing evidence to date has demonstrated this phenomenon. Primary 
suppression of gluconeogenic enzymes could result from endotoxin. McCallum, 
however, showed that there was no effect on hepatic phosphoenolpyruvate 
carboxykinase {PEPCK) activity when endotoxin was added directly to liver 
homogenates or hepatocyte cultures {52). Since the lipid A portion of the 
endotoxin molecule is obviously quite lipophilic and direct membrane effects 
have been demonstrated, then a primary effect of endotoxin on the heptocyte 
remains a possibility. Secondary effects of endotoxin mediated through Kupffer 
cells is probably playing the major role in the gluconeogenic failure in this 
study. McCallum demonstrated profound decreases in PEPCK activity when 
media from endotoxin incubated Kupff er cells was added to normal hepatocytes 
{52). In our study, the liver {day 4) with the largest complement of new Kupffer 
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cells show the most profound depression of gluconeogenesis, suggesting that 
mono kines liberated from these Kupff er cells contributed significantly to the 
metabolic failure observed in the 4 day rats. 
This effect of Kupff er cells on hepatocyte gluconeogenesis certainly was 
observed in the endotoxic state. However, many phenomena observed in the 
endotoxic state may be merely an exaggeration of the so called normal 
interactions between Kupffer cells and hepatocytes. The data from Table 4 on 
in vivo gluconeogenesis demonstrates that this exaggeration may indeed be the 
case. With conditions maximized for gluconeogenic production of new glucose, 
the 4 day rats demonstrated a definite inferior capacity to elevate the blood 
glucose in response to gluconeogenic challenge. Since this is an in vivo study, 
however, no comment can be made whether or not this represents a primary 
hepatocyte dysfunction or whether this is due to the hepatocytes existing in a 
milieu of Kupff er cells producing mono kines which may act to suppress 
gluconeogenesis (26). Other studies have shown that virtually all functions of 
the intact liver are normal in the newly regenerated rat liver. Thus, it is 
unlikely that this particular enzyme system would be defective in the hepatocytes 
without extracellular influences such as monokines. This theory could be tested 
most easily by an isolated hepatocyte short term culture which would be Kupffer 
cell free. Another consideration which could not be addressed in this study is 
the extrahepatic glucose consumption which may affect a blood glucose level. 
Measuring only plasma glucose levels does not afford one to comment on either 
rates of appearance or disappearance of glucose into the plasma. It is possible 
that the 4 day rat was exhibiting a more profound peripheral utilization of 
glucose and therefore could not elevate his glucose as high as the control rat. 
However, if we assume that the mannoheptulose injection prior to the test 
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blocked insulin effects on all insulin sensitive tissues, then perhaps this argument 
is minimized. 
As others have previously shown, we have demonstrated that the 4 day 
rats indeed had hyperphagocytic livers indicative of increased of Kupffer cell 
mass and activity, therefore it is highly unlikely that the increased endotoxin 
sensitivity of these rats is due to a failure of the mononuclear phagocyte system 
to clear and process endotoxin. Rather, this speaks for an exaggeration of the 
normal host response in dealing with endotoxin. Grossly, most of the colloidal 
carbon appeared to be taken up in the newly regenerated liver as similar to 
that seen in control livers, reinforcing the fact that the Kupffer cells in the 
new liver are more than adequately performing their phagocytic function. We 
may assume then, that these new Kupffer cells are also performing their function 
in clearing the injected endotoxin dose. At this point I would like to summarize 
the experimental findings and then present a unifying hypothesis to explain the 
experimental results. Because of the limited studies performed, obviously no 
firm conclusions can or should be drawn from these studies. However, a unifying 
hypothesis is offered to provide a direction for future studies in this area. 
These studies demonstrated that the liver generation model is, indeed, a 
useful tool to study Kupffer cell hepatocyte interactions, specifically in the 
area of endotoxic shock. A rat with a newly regenerated liver exhibits profound 
sensitivity to intravenous endotoxin in regards to lethality and glucoregulation. 
Qualitatively the lethality imposed on this 4 day rat by endotoxin does not 
appear to be any different from a control rat, a recently operated rat, or one 
further along in the regenerative process. However, the temporal sequence to 
the development of irreversible shock seems to be hastened in the 4 day rat. 
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Metabolically, the rat undergoes a much quicker and more profound process of 
hyperlactacidemia and hypoglycemia which appears to be due to a failure of 
mainly gluconeogenesis. In the nonendotoxic state, the 4 day rat appears to 
have inferior gluconeogenesis when compared to control rats, thus the organismic 
milieu which these hepatocytes reside in may already predispose to a dysfunction 
of gluconeogenesis even prior to induction of endotoxicosis. The 4 day rats' 
mononuclear phagocyte system is significantly more functional in regards to 
phagocytosis of colloidal carbon than is control rats. Thus the MPS appears to 
be hyperfunctioning rather than malfunctioning. 
The following unifying hypothesis is offered to fit the experimental data 
from this study as well as previous studies performed which have investigated 
endotoxin liver interactions. In the physiologic state, the Kupff er cells normally 
phagocytize and process endotoxin in a constant fashion over the long run. 
They probably adapt to this continuous flow of endotoxin through the portal 
venous system as the organism will not go into septic shock every time there is 
a seeding of endotoxin into the portal system. Therefore, there is theoretically 
a continual baseline release of mediators in response to endotoxin. These 
mediators are released in an exaggerated fashion when the load of endotoxin 
is overwhelming as is seen in septic shock. These mediators such as MILA, 
MIRA and interleukin 1, exhibit profound influences on the metabolic behaviour 
of the neighboring hepatocytes. The injured liver prioritizes the maintenance 
of the gluconeogenic pathway to avoid dangerous hypoglycemia in the immediate 
postinjury period. Possibly, this hepatocyte "machinery" then shifts into cell 
di vision processes as 
gluconeogenic processes. 
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regeneration continues rather than maintaining 
This shift of intracellular priorities, along with the 
increased Kupffer cell responses, combine to produce the profound sensitivity 
to endotoxin observed in the day 4 rats. 
The MPS cells repopulate the regenerated liver and spleen either by local 
division and/or bone marrow repopulation. They begin a slow process of degrading 
endotoxin in the portal circulation while becoming somewhat tolerant of 
endotoxin. However, in the 4 day liver, when the MPS cells are quite new in 
their environment, they may react in a profoundly exaggerated manner to 
endotoxin, both because they have no tolerance and their sheer numbers are 
increased. Indeed, splenectomized animals exhibit relative resistance to 
endotoxin (1). As the Kupff er cells reside in the hepatic sinusoids over time, 
this tolerance to endotoxin is reflected in the fact that th~ 9 day rats have 
now lost their profound sensitivity exhibited in the 4 day rats and by 16 days, 
this tolerance may actually connote a protective effect because of the increased 
ability of the phagocyte to degrade endotoxin. Previous studies have shown 
that this hyperphagocytic activity persists for up to 6 months in the rat liver. 
This development of tolerance and the process of desensitization would also 
explain why innoculations of endotoxin can make a rat markedly insensitive to 
otherwise lethal doses of endotoxin. This phenomenon may also help to explain 
the so called process of RES blockade which may actually be a sensitization of 
the Kupffer cells to hypersecrete physiologic mediators which may become 
pathophysiologic in these amounts and the amounts released during septic shock. 
SUMMARY OF CONCLUSIONS 
1. Partial hepatectomy (7096) with subsequent regeneration provides an 
appropriate method to study the role of hepatocyte-Kupffer cell 
interactions in the development of endotoxic shock. 
2. Regardless of the timing of endotoxin injection following hepatectomy, 
rats develop profound hypoglycemia and hyperlactacidemia during late 
endotoxic shock. 
3. Rats which are four days post hepatectomy are profoundly sensitized to 
endotoxic shock, while rats which are sixteen days post-hepatectomy 
appear to experience relative protection from the lethal effects of 
intravenous endotoxin. 
4. In vivo gluconeogenesis is impaired in the four day post-hepatectomy rat. 
5. The four day post-hepatectomy rat Ii ver is hyperphagocytic as 
demonstrated by the accelerated clearance of intravenous colloidal carbon. 
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